Navigation Links
Onyx Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Date:9/4/2009

EMERYVILLE, Calif., Sept. 4 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Morgan Stanley Global Healthcare Unplugged Conference on Monday, September 14, at 10:55 a.m. Eastern Time. Interested parties may access a live webcast of the presentation on our website at: http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available one hour following the conclusion of the presentation through October 14, 2009.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
2. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug-Resistant Influenza at 2009 ICAAC Annual Meeting
4. Oramed Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference
5. NovaBay(R) Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference September 10, 2009 in New York City
6. Optimer Pharmaceuticals to Present at September 2009 Investor Conferences
7. Arena Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
8. OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences
9. Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
10. Transcept Pharmaceuticals to Present at the BioCentury Thomson Reuters Newsmakers in the Biotech Industry Conference on September 16, 2009
11. Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... the launch of several innovative new programs to aid ... current economic climate. The first is aimed at ... services over a period of 6, 12, 18, or ... companies. The second is aimed at more established ... 6 to 12 month period at discounted rates, and ...
(Date:12/14/2009)... International, Inc. (Pink Sheets: DYAI) ("Dyadic") announced today ... Scripps Research Institute ("Scripps") by entering into an ... Dyadic,s patented and proprietary C1 fungus ("C1"). ,, ... relationship between the two organizations which began in ... the C1 genome for the first time. The ...
(Date:12/14/2009)... Boston Scientific Corporation (NYSE: BSX ) today ... billion aggregate principal amount of its senior notes under ... consists of $850 million of 4.50 percent notes due ... January 2020 and $300 million of 7.375 percent notes ... the net proceeds for general corporate purposes, including prepaying ...
(Date:12/14/2009)... Decision Resources, one of the world,s leading research ... finds that, owing to the launches of several ... increase more than sevenfold from $790 million in ... United States, France, Germany, Italy, Spain, the United ... entitled Atrial Fibrillation finds that a ...
Breaking Biology Technology:The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2
... The human eye uses tiny muscles to focus on ... lenses, but some sensors do not require these external ... College of Engineering are investigating a liquid lens ... be used in a variety of commercial applications, including ...
... of a two-part opinion piece on ethanol. Read part one. ... - The environmental arguments surrounding ethanol are plentiful and ... and ozone. These studies were based on computer models. Studies of ... California Air Resources Board and others show that in ...
... - Madison Area Technical College 's new biodiesel ... help educate the technicians that will be entrusted with ... developed as part of a joint project between MATC ... oil recovered from a restaurant's deep fryer and blends ...
Other Biology Technology:"Smart" lenses hold commercial potential 2Last ethanol article you'll ever need to read, Part II 2Last ethanol article you'll ever need to read, Part II 3Last ethanol article you'll ever need to read, Part II 4MATC bio-diesel reactor to support training 2
(Date:12/15/2009)... Fla. When treating devastating brain diseases such as ... bags to find something to help a patient. , ... help the vast majority of patients with ataxia ... coordination. , University of Florida neurologists are trying to ... Challenge grant from the National Institute of Neurological Disorders ...
(Date:12/15/2009)... San Diego, California, has been awarded an accreditation ... on results of a recent onsite inspection. ... this national recognition and congratulated for the "excellence ... GenWay Clinical Laboratory is one of nearly 7,000 ... Program, begun in the early 1960s, is recognized ...
(Date:12/15/2009)... German ., Despite the fact that physical ... vary as to how space is encoded in their ... such as ,left, right, front, back, to talk about ... east, west, at all times for all scales: "The ... an snake by your Northern leg". Whether not only ...
Breaking Biology News(10 mins):UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3More than a jump to the left 2Omnicell Announces Second Quarter 2009 Results 52608 1Omnicell Announces Second Quarter 2009 Results 52608 2Omnicell Announces Second Quarter 2009 Results 52608 3Omnicell Announces Second Quarter 2009 Results 52608 4Omnicell Announces Second Quarter 2009 Results 52608 5Omnicell Announces Second Quarter 2009 Results 52608 6Omnicell Announces Second Quarter 2009 Results 52608 7Omnicell Announces Second Quarter 2009 Results 52608 8Omnicell Announces Second Quarter 2009 Results 52608 9Omnicell Announces Second Quarter 2009 Results 52608 10Omnicell Announces Second Quarter 2009 Results 52608 11Omnicell Announces Second Quarter 2009 Results 52608 12Immucor Announces Fiscal Fourth Quarter Results 52606 1Immucor Announces Fiscal Fourth Quarter Results 52606 2Immucor Announces Fiscal Fourth Quarter Results 52606 3Immucor Announces Fiscal Fourth Quarter Results 52606 4Immucor Announces Fiscal Fourth Quarter Results 52606 5Immucor Announces Fiscal Fourth Quarter Results 52606 6Immucor Announces Fiscal Fourth Quarter Results 52606 7Immucor Announces Fiscal Fourth Quarter Results 52606 8Immucor Announces Fiscal Fourth Quarter Results 52606 9Immucor Announces Fiscal Fourth Quarter Results 52606 10Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 1Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 2Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 3Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 4Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 5Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 6Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 7Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 8Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 9Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 10Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 11Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 12Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 13Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 14Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 15Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 16Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 17Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 18Oclaro Reports Positive Adjusted EBITDA in First Post Merger Quarter 52605 19
... longtime University of Houston engineering professor to spend next ... , Fazle Hussain, professor of mechanical engineering at UH,s ... the Gordon and Betty Moore Distinguished Scholars Program appointment ... applied sciences. The program, started in 2000 with a ...
... Carolina State University have answered a fundamental question of ... them to function, a finding that could provide a ... and related diseases. , In a study published this ... State scientists show for the first time that the ...
... biological clock and extend their lifespan at the same ... study, published online this month in Molecular Genetics ... of a tradeoff between reproduction and longevity. , Popular ... you reproduce, the shorter you,re going to live," said ...
Other Biology News:Celebrated UH researcher invited to Caltech as distinguished scholar 2Scientists present 'moving' theory behind bacterial decision-making 2Old flies can become young moms 2
... kit is used to quantitate double-stranded DNA (dsDNA) ... or protein. With this kit, DNA is stained ... with a VersaFluor or other fluorometer. The kit ... per ml to 5 micrograms per ml and ...
... (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide), 50mg/vial. MTT is a ... living cells to yield a dark blue ... and even freshly dead cells do not ... is a component of Chemicons MTT assay ...
Piperazine-N',N'-bis(2-ethanesulfonic acid), monosodium salt...
Mouse monoclonal [CAT-2] to Chloramphenicol Acetyltransferase...
Biology Products: